SAN FRANCISCO — The use of high-dose oral vitamin therapy failed to reduce the risk of cardiovascular events in the Trial to Assess Chelation Therapy (TACT), a 2x2 factorial-design, randomized, double ...
Randomized phase III study of S-1 alone versus S-1 plus docetaxel (DOC) in the treatment for advanced gastric cancer (AGC): The START trial update. This is an ASCO Meeting Abstract from the 2011 ASCO ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results